[Clinical evaluation of a therapeutic complex incorporating linetol and ascorbic and nicotinic acids for the correction of lipid metabolic disorders in children with glomerulonephritis].
Makovetskaia
G A
GA
Rusakova
N V
NV
Lebedev
A A
AA
D000293:Adolescent; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000097:blood / Q000628:therapy*; D006801:Humans; D008055:Lipids / Q000097:blood*; D009404:Nephrotic Syndrome / Q000097:blood / Q000628:therapy; D009525:Niacin / Q000627:therapeutic use*
D004338:Drug Combinations; D005231:Fatty Acids, Unsaturated; D008055:Lipids; C014642:linethol; D009525:Niacin; D001205:Ascorbic Acid
Klinicheskaia otsenka lechebnogo kompleksa, vkliuchaiushchego linetol, askorbinovuiu i nikotinovuiu kisloty, dlia korrektsii narusheniĭ lipidnogo obmena u deteĭ s glomerulonefritom.